title: Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug class.
authors.affiliation: Division of General Internal Medicine/Division of Cardiology, University of Nevada School of Medicine, Reno, Nevada, USA. mbloch@aol.com
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Bloch
authors.forename: Jan N
authors.initials: JN
authors.lastname: Basile
mesh_terms: D000959:Antihypertensive Agents / Q000145:classification / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents